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The characterization of a  transmissible agent capable of inducing DNA and 
thymine degradation was described in the preceding report (1). Evidence indi- 
cates that the surface coating of the agent is rich in lipids, and for this reason 
it is suggested that  this agent be tentatively referred  to as a  lipovirus. This 
report describes the demonstration of a  toxic factor found in human cell cul- 
tures  infected  with  this  lipovirus.  This  toxin,  non-transmissible serially,  is 
capable of  inducing severe fatty degeneration of  cultured human cells.  Pre- 
liminary in vivo studies are also described. 
Materials and Methods 
The cultivation  of primary human amnlon or "liver" cells and the production of the trans- 
missible agent were similar to that described in the preceding report  (1). The lipogenic toxin 
was found in the superuatant fluid after the removal of infectious particles by centrifugation 
at 14,000 m,~t  for 1 hour in a Servall SS-1 angle head centrifuge; this has been described in the 
section on the production of the cell-free form of this transmissible agent in the preceding 
report  (1). Unless specified otherwise, toxin prepared from liver cells nourished in Holmes' 
synthetic medium was used. 
Induction of Fatty  Degeneration.--Primary  human amnion, "liver," or mouse fibroblast cells 
were grown as monolayers on glass coverslips about 6 to 8 mm in diameter. Each coverslip 
was transferred  to a stoppered culture tube (15  X  150 ram) containing 0.7 ml of nutrient 
medium (5 per cent inactivated horse serum in Eagle's basal medium). 0.3 ml of toxin was 
added to each culture. The culture was placed on a roller (12 revolutions per hour) at 36°C. 
After 72 hours, the coverslip was removed, rinsed once in Eagle's basal medium, fixed  in forma- 
lin, and stained with oil red O or Sudan IV (2). Appropriate controls were included in each 
experiment. 
For the analysis of fatty acid, cells were grown in milk dilution bottles and were harvested 
by the usual trypsinlzation.  The trypsinized cells were washed 3 times with  10 ml each of 
Eagle's basal medium. The washed cells were then kept frozen at below --20°C. 
* This work was supported  by Grants (SF  131, E553CS, and RG 6235 (C2)) from the 
United States Public Health Service, National Institutes of Health, and aided by Grant No. 
C-3117 (C4) from the American Cancer Society. 
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Lipid  Analyses.--Total fatty  acids were determined by  Dole's method (3). Gas 
chromatographic analyses were done as described elsewhere (4) using a Research Specialties 
Company  instrument equipped with a strontium ionization  detector. 
DNA Determination.--The  washed cells, after lipid extraction, were assayed for DNA by 
the diphenylamine  reaction (5). 
ttistologic Studies.--Animals were sacrificed  by etherization and tissue slices were fixed  in 
10 per cent neutral formalin. Frozen sections were stained with either Sudan IV or oil red 0 
and hematoxylin.  Paraffin-embedded  sections  were stained with hematoxylin  and eosin. 
The excellent assistance of Messrs. David Pollard and Kenneth Taylor is gratefully ac- 
knowledged. 
RESULTS 
ttistochemical  Evidence of Fatty Degeneration.--2  to 4 days after the addition 
of  toxin,  fatty degeneration was  regularly produced  in  the  primary human 
amnion, "liver" cells, and L  strain of mouse fibroblasts nourished in 5 per cent 
inactivated  horse,  human,  or  calf  serum  diluted  in  modified  Eagle's  basal 
medium  (l).  Fatty  degeneration was  indicated  by  a  significant  increase  of 
sudanophilic droplets in  the cytoplasm of toxin-treated cells as  compared to 
untreated control cultures  (see Fig.  1).  These sudanophilic droplets were ex- 
tractable  with  ether-alcohol.  Similar  fractions  prepared  from  liver  cultures 
killed  by freeze-thawing failed  to  induce  a  similar  increase  of  sudanophilic 
droplets.  Like most  fatty degenerative  changes,  this  process  was  reversible 
after the removal of the  toxin.  Prolonged exposure, however, frequently led 
to slow disintegration of the affected cells.  Passages of such disintegrated cul- 
tures failed to induce fatty degeneration of recipient cultures, indicating  the 
absence of replication of the factor responsible for fatty change. There was sug- 
gestive evidence that overcrowded cultures showed less fatty changes. 
Release of Toxin from Other Culture  Systems Infected  by the Lipovirus.--To 
exclude the possibility that  the lipogenic toxin is released only by lipovirus- 
infected "liver" cultures  nourished  in  Holmes'  chemically defined  medium, 
similar  fractions  obtained  from lipovirus-infected "liver,"  chick  embryonic, 
and primary human amnion cultures, all nourished in 5 per cent  inactivated 
horse serum diluted in a  modified Eagle's basal medium, were tested for lipo- 
genic activity. Six such fractions have been tested; all induced extensive accu- 
mulation of sudanophilic  droplets in  the cytoplasm. 
Preliminary  Characterization  of  the  Lipogenic  Toxin.--The  toxic  fraction 
retained its lipogenic property after storage at 37°C for 10 days and 0-4°C or 
below -60°C for at least 1 1/2 years. Heating at 58°C for 30 minutes eliminated 
the lipogenic activity. Dialysis against  1000 times its volume of 0.85 per cent 
sodium chloride at 0--4°C for 4 hours with constant stirring failed to remove its 
activity. Two lots of toxin, which had been treated with 0.1  mg of crystalline 
trypsin (pH 8.0)  at 37°C for 1 hour followed by the addition of 0.5 nag of soy- 
bean trypsin inhibitor,  retained their lipogenic activity. A  mixture of 0.3  ml 
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fatty changes in liver  cultures similar  to that induced  by  toxin not  treated 
with gamma globulin. The gamma globulin used in this experiment was kindly 
furnished by Dr. Geoffrey Edsall of the Massachusetts Department of Public 
Health; it was prepared from about 1000 units of outdated human blood and 
antibody against poliovirus type 1 was demonstrable at 0.2 per cent. Serums 
collected from rabbits immunized with the lipovirus and its toxin by procedures 
described in the preceding report (1) did not neutralize this lipogenic activity 
when tested at a dilution of 1/10. Various lots of toxic fractions varied in their 
lipogenic potency. 1 of 8 preparations, obtained from liver cultures nourished 
in Holmes' medium, was found completely inactive; none was found llpogenic 
when tested at a dilution of 1/10. It should be emphasized that no attempt was 
made  to  detect  partial  reduction of lipogenic  activity in  these  preliminary 
studies. 
Failure  to Demonstrate Similar Lipogenic Activity from  Cultures Infected by 
Other Viruses.--Since  fatty degeneration  of  mouse  ascific cells  infected by 
certain arbor viruses,  and HeLa Cells infected by Coxsackie B3  virus have 
been described (6), experiments were designed to determine whether or not a 
lipogenic toxin (dissociable from infectivity) can be demonstrated in cultures 
infected by other viruses. The following types of preparations have been tested: 
1.  Liver cultures in Holmes' medium were infected with vaccinia or herpes 
simplex viruses. Mter complete cell destruction, the culture fluid was centri- 
fuged at 14,000 m'M for 1 hour in a SS-1 Servall angle head centrifuge, and the 
upper  ~  of the supernatant fluid was collected. Since this fluid was still in- 
fectious, it was kept at 37°C for 7 days and was tested for lipogenic activity. 
At this time, fluid obtained from herpes-infected culture was no longer infec- 
tious, while that from vaccinia produced only early cytopathic change 3 days 
after introduction to a recipient culture. It should be noted that the llpogenic 
toxin of the lipovirus was stable at 37°C for 10 days. 
2.  Fluids from chick embryonic cultures infected with Rous sarcoma and 
parainfluenza  1  viruses;  mouse  embryonic  cultures  infected  with  polyoma 
virus; liver cultures infected with adeno 3, polio  1, and Coxsackie B1 viruses; 
conjunctival cultures infected with polio 2 virus; and allantoic fluid from chick 
embryos infected with influenza virus group A strain W.S. were centrifuged at 
2000 P.PM for 10 minutes.  The supernatant fluids of Rous and polyoma virus- 
infected cultures were tested on liver cells. Those obtained from the remaining 
viruses were tested on mouse fibroblasts, strain L. 
Small increases in visible fat were noted in cultures treated with  polio 2, 
influenza A, and parainfluenza 1 viruses.  These increases were slight in com- 
parison  with  those  induced by the  lipogenic  toxin.  The  other  viruses  were 
completely inactive. 
Increase in  Total  Fatty  Acid Content of Tozin-Treated  Cells.--To  find out 
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alteration  of the physical  state  of pre-existing  lipids  or due  to an increase  in 
uptake and/or synthesis, total fatty acids of toxin-treated and control cultures 
were determined.  The results of 4 experiments are shown in Table I. A five- to 
elevenfold increase in total fatty acids per unit weight of DNA is demonstrated 
in 3  of the 4  experiments.  Experiment  2,  which shows only a  slight  increase, 
was performed during the early phase of this work. These results indicate that 
the lipogenic toxin induced a significant increase in the uptake of lipid from the 
culture medium and/or in lipid synthesis. 
TABLE I 
Lipogenic Toxin on the Total Fatty Acid and DNA Ratios of Cultured Human Cells 
Total fatty  Total fatty  Exp.*  Cellar  Toxin  DNA§  acidll  acid/DNA 
1  PA 
PA 
L 
L 
L 
PA 
PA 
No 
Yes 
No 
Yes 
Yes 
No 
Yes 
L  Heated  toxin 
L  Heated  toxin 
L  Unheated toxin 
L  Unheated  toxin 
0.14 
0.05 
0.26 
0.18 
0.12 
0.08 
0.07 
0.59 
0.70 
0.58 
0.58 
* Different lots of toxin were used in each experiment. 
:~ PA =  primary human amnion, and L =  liver. 
§ Expressed as rag. 
[] Expressed as microequivalents. 
1.3 
4.7 
2.5 
2.6 
2.3 
0.2 
1.1 
3.6 
3.4 
33.8 
28.7 
9 
94 
10 
14 
19 
3 
16 
6 
5 
59 
49 
Constiluent Fatty Acids of Toxin-Treated and Control Liver Cells.--The relative 
percentage  composition of the fatty acids of toxin-treated  cells,  control cells, 
and serum is given in Table II. There was an apparent increase in C18 dienoic 
acid at the expense of C18 monoenoic acid in the toxin-treated cells, while other 
fatty acids were not much affected.  If liver cells behave similarly to strain L 
fibroblasts  (4), they would synthesize little,  if any, Cls dienoic acid, and would 
obtain this acid from exogenous sources such as the serum. Since there was not 
only an increase in the percentage of this acid in the lipids of the toxin-treated 
cells, but in the total fatty acid content as well (Table I), it must be concluded 
that at least some of the excess lipid was derived from the serum, and that the 
observed sudanophilia was not due simply to an alteration in the physical state 
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Demonstration  of a Cell-Clumping  Factor.--Since some of the fatty acids in 
the  toxin-treated cells apparently were derived from the serum,  experiments 
were designed to determine whether this lipogenic toxin would also induce fatty 
changes in liver ceils nourished in Holmes' chemically defined medium (1). It 
was regularly observed that 1 day after the addition of the toxic fraction most 
of the ceils were detached from the coverslip while some remained as clumps 
of rounded  cells,  making histochemical study of fatty changes  difficult.  (See 
Fig.  2). The presence of 1 per cent human,  horse,  rabbit, guinea pig, or calf 
serum in  the  test  system prevented cell clumping or detachment.  A  human 
gamma globulin preparation when  tested  at a  final concentration  of 0.4  per 
cent failed to prevent cell dumping. This cell-detaching factor differed from the 
TABLE  II 
Major Fatty Acids of Normal and Toxin-Treated Liver Cells 
Fatty acid  Relative per cent 
Chain length  Degree of saturation  Normal cells  Toxin-treated celL,  Serum 
14 
16 
16 
18 
18 
18 
Saturated 
Saturated 
Monoenoic 
Saturated 
Monoenoic 
Dienoic 
4.3 
16.7 
10.3 
12.1 
33.3 
22.3 
1.9 
17.5 
7.1 
15.6 
23.8 
33.2 
0.4 
10.6 
1.4 
25.1 
12.4 
49.1 
Column packing: 20 per cent Craig polyester succinate on chromosorb W (Wilkens Instru- 
ment and Research, Inc., Walnut Creek, California); temperature:  180°C; argon flow rate: 
60 ml/min. Small amounts of other fatty acids were not included in these calculations. Values 
are based on the average of duplicate analyses of two different samples. 
lipogenic factor in its stability to heating at 58°C for 30 minutes. It was inacti- 
vated, however, by boiling for 5 minutes. As with the lipogenic factor, the cell- 
detaching  factor  was  stable  at  0-4°C  or  below  -60°C  for  at  least  several 
months;  was non-dialyzable; was inactive when tested at a  dilution of 1/10; 
and was not demonstrated in similar preparations obtained from cultures killed 
by  the  vaccinia  and  the  herpes  simplex virus,  or  by freeze-thawing.  1  of 6 
preparations  tested  thus  far was found inactive. 
Preliminary  Study  of  the  In  Vivo  Effect  of  the  Lipogenic  Toxin.--White 
Swiss mice, weighing approximately 20 gm, did not show any overt effect after 
receiving repeated parenteral injections of the toxin. Groups of 4 mice received 
5 daily injections of 0.5  cc of toxin, either intravenously or intraperitoneally, 
and were sacrificed serially 1 to 10 days following the last injection. The livers 
of the toxin-treated mice showed moderate increases in the amounts of lipid, 
as compared with control animals receiving comparable injections of Holmes' 
medium. This lipid was seen as an accumulation of sudanophilic droplets within 964  CULTURED  HUM.AN  CELLS 
the cytoplasm of the liver cells centrally and midzonally. No consistent changes 
were found in  the liver  cells  on hematoxylin and  eosin staining.  Sudan IV 
preparations of the other major viscera, including the central nervous system, 
were not remarkable. In 2 further experiments, groups of 15 white mice and 
9 white rats were sacrificed 3 to 22 hours after a single intraperitoneal injection 
of 0.5 cc of toxin. Under these conditions there was no apparent difference in 
the amount of sudanophilic lipid in the liver cells of the test animals as com- 
pared  with  equal  numbers  of appropriate  controls.  The  significance of  the 
suggestive findings in the above assays, which employed repeated injections, 
will require testing in much larger numbers of animals. 
DISCUSSION 
The release  of a  toxic product capable  of inducing fatty degeneration in 
cultured human and mouse cells from lipovirus-infected cultures appears well 
established. That this is another unique property of this lipovirus is indicated 
by our failure to effect the release of a similar toxin from cultures infected by 
the vaccinia, herpes simplex, adeno 3, polyoma, polio 1 and 2,  Coxsackie B1 
parainfluenza 1, influenza A, and Rous sarcoma virus. The fact that it is dis- 
sociable  from infectivity distinguishes it  from other  viral  toxins  which  are 
intimately associated with infectious particles. 
This demonstration of a diffusible toxin which is capable of producing exten- 
sive  fatty degeneration in  cultured  human  cells  stresses  the  importance  of 
examining diffusible products of virus-infected cells  for biological activities. 
With the exception of interferon (7) or interferon-like substance (8), published 
reports on biologically active diffusible products of virus-infected cells are con- 
spicuously meager. There are several reports describing cell-detaching factors 
from cells infected by the adeno- or polioviruses (9);  these factors are neutral- 
ized by specific  antiserum and are,  therefore, presumably specific  viral com- 
ponents. 
The potential importance of this lipogenic toxin can be comprehended more 
readily if one takes into consideration other unusual properties of the lipovirus 
(1).  The lipovirus is  presumably non-immunogenic, survives in  special  cells 
(e.g., sarcoma 180 cells) in vivo for at least 2 months, and presumably does not 
circulate, owing to  the presence of the ubiquitous lipoprotein-like serum in- 
hibitor. It is tempting to speculate whether, in the appropriate in vivo situation, 
infection with or survival of the lipovirus might be accompanied by slow, con- 
tinued release of the  toxin into the  circulatory system with resultant fatty 
changes at susceptible sites. To substantiate this hypothesis, one would have to 
establish some replication of the lipovirus in experimental animals, demonstrate 
its  lipogenic  activity in  vivo,  and  achieve  repeated  isolations from  clinical 
materials. Although our preliminary experimental results indicate a  slight to R.  S.  CHANG~  R.  P.  GEYER~  AND  S.  B.  ANDRUS  965 
moderate increase in sudanophilia of the livers of white Swiss mice receiving 
this toxin under the described experimental conditions, further in dvo studies 
are required because of the small number of animals used. Our failure to re- 
isolate  the lipovirus  was  described  in  the preceding report  (1);  the clinical 
materials used, however, were exclusively the acute phase blood collected from 
infectious hepatitis patients. Isolation attempts, using other clinical materials, 
are currently being made. Although chick embryos and white Swiss mice did 
not develop overt disease following the introduction of the lipovirus (1), it is not 
known whether limited multiplication of this virus occurs in the apparently 
healthy  animals.  Experiments  designed  to  elucidate  this  point  are  now  in 
progress. 
SIrU-u~kR¥ 
The release of a toxic product from cultured human cells infected by a new 
cytopathic agent (the lipovirus) was described. This toxin was dissociable from 
the infectious particles. It induced sudanophilia of human and mouse cells, an 
increase in the total fatty acid content, and a change in the major constituent 
fatty acids.  Similar toxin was not demonstrated in cultures infected by the 
vaccinia herpes simplex, adeno 3, polyoma, polio 1 and 2, Coxsackie B1, para- 
influenza A, and Rous sarcoma viruses. Preliminary characterization indicated 
that this toxin was resistant to tryptic digestion and could not be dialyzed or 
neutralized by human gamma globulin.  It  was  inactivated at  58°C  for 30 
minutes, but stable at 37 °, 4  °, and -60°C. The significance of these findings is 
discussed. 
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EXPLANATION OF PLATES 
PLATE 104 
FIG.  1.  Sudanophilia in cultured liver cells.  A.  toxin-treated;  B.  control; and  C. 
area of maximum sudanophilia seen in some control cultures. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. llS  PLATE  104 
(Chang et al.: Cultured human cells) PLATE 105 
FIG.  2.  "Clumping"  of liver cells. A.  treated  with  cell-clumping factor;  and  B. 
control. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  115  PLATE 10S 
(Chang et al.: Cultured human ceils) 